Suppression of innate immunity (natural killer cell/interferon-γ) in the advanced stages of liver fibrosis in mice. - Wikidata - wikimedia - TriplyDB

Suppression of innate immunity (natural killer cell/interferon-γ) in the advanced stages of liver fibrosis in mice.

Suppression of innate immunity (natural killer cell/interferon-γ) in the advanced stages of liver fibrosis in mice.

http://www.wikidata.org/entity/Q34816420

about

The Immune Landscape in Nonalcoholic Steatohepatitis.Natural Killer Cells and Liver Fibrosis Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?Targeted Therapies in Liver Fibrosis: Combining the Best Parts of Platelet-Derived Growth Factor BB and Interferon Gamma Natural killer cells in liver disease Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets A proteomics approach to identifying key protein targets involved in VEGF inhibitor mediated attenuation of bleomycin-induced pulmonary fibrosis Evolving therapies for liver fibrosis.Cirrhosis, liver transplantation and HIV infection are risk factors associated with hepatitis E virus infection The CXCR3(+)CD56Bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis C Liver myofibroblasts from hepatitis B related liver failure patients may regulate natural killer cell function via PGE2.IL-13 promotes collagen accumulation in Crohn's disease fibrosis by down-regulation of fibroblast MMP synthesis: a role for innate lymphoid cells?Hepatic inflammation and fibrosis: functional links and key pathways.Treatment with 4-methylpyrazole modulated stellate cells and natural killer cells and ameliorated liver fibrosis in mice.Toll-like receptors in liver fibrosis: cellular crosstalk and mechanisms Chronic inflammation, immune escape, and oncogenesis in the liver: a unique neighborhood for novel intersections.Blockade of Retinol Metabolism Protects T Cell-Induced Hepatitis by Increasing Migration of Regulatory T Cells.Natural killer and natural killer T cells in liver fibrosis Cultured Mycelium Cordyceps sinensis allevi¬ates CCl4-induced liver inflammation and fibrosis in mice by activating hepatic natural killer cells.Alcohol dehydrogenase III exacerbates liver fibrosis by enhancing stellate cell activation and suppressing natural killer cells in mice.Liver Injury and the Activation of the Hepatic Myofibroblasts.Toll-like receptor signaling in liver regeneration, fibrosis and carcinogenesis Hepatic stellate cells, liver innate immunity, and hepatitis C virus Immune Regulation of Intrahepatic Regulatory T Cells in Fibrotic Livers of Mice.Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-β-dependent emperipolesis in HBV cirrhotic patients.Retinoic acids and hepatic stellate cells in liver disease.Immunological orchestration of liver fibrosis.Interaction of hepatic stellate cells with diverse types of immune cells: foe or friend?Pivotal roles of ILCs in hepatic diseases.Natural killer T cells in liver injury, inflammation and cancer.Targeting Hepatic Fibrosis in Autoimmune Hepatitis.Reversal of liver cirrhosis: current evidence and expectations.Identification and characterization of functional Smad8 and Smad4 homologues from Echinococcus granulosus.Targeting inflammation for the treatment of alcoholic liver disease.Intrahepatic NK cells function suppressed in advanced liver fibrosis.Rapidity of fibrosis progression in liver transplant recipients with recurrent hepatitis C is influenced by toll-like receptor 3 polymorphism.HIV, HEV and cirrhosis: evidence of a possible link from eastern Spain.Suppression of Natural Killer Cell Activity by Regulatory NKT10 Cells Aggravates Alcoholic Hepatosteatosis.NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner.Exploring the Mechanism of Dangguiliuhuang Decoction Against Hepatic Fibrosis by Network Pharmacology and Experimental Validation.

P2860

Q26747323-E460F276-153A-4F3B-BE1A-1302B9A26438 Q26767448-DA4C234D-C6A3-42C0-832D-1280C0F04A91 Q26769611-E78209C2-1F2B-49A1-A349-A61459B2CBA0 Q26779055-74B7F426-FAD5-46C5-AD06-6044A8D79ADC Q27025451-887B4C93-3CF8-47EC-BA15-97E567846650 Q27025680-6093AF57-89FB-4FE1-95D1-13DD79011C4C Q28383207-76F87FE0-C4AC-4D3B-8C53-B056B9AFEF70 Q30539166-96728870-8145-4C15-B754-221843EB115E Q33961593-32B454FD-400A-4091-BBE9-EBDFC9C82527 Q34335634-EDA9CD00-FD26-44A5-B3D9-F7CEBE79C6BA Q34515512-5A55611A-8CA8-4F79-BF5A-B87023EF65DE Q34540573-F44A5491-6B3C-49D5-A102-BFF9E99F3CCD Q35213917-3007F2E7-18AC-44C3-978D-C6F7583573F2 Q35646227-E7A2E38C-E650-42A3-82E2-86E35FB1D85D Q35977675-299D0D8A-AB89-426C-9ADB-E11A4219ED17 Q36055039-7C87B4AC-7F18-4D89-B88F-BE23FEAEA462 Q36356763-F4E0A784-774B-4180-97C8-7F3CFA9ED2B9 Q36553227-D381BCBA-6283-48C2-8EED-5339B9052CA1 Q36579286-8AF4E2F0-4D85-4D90-A6F4-0C4A33631485 Q36901235-9495BA51-023A-40A1-9888-3691C5CBA7AD Q37109402-0E55E848-D14D-4550-A4DC-B6D8EE2CF668 Q37125483-9F583152-2850-4B91-B17A-2F3676CD802E Q37607847-81738002-3E52-4F68-A31F-4EE3028050A0 Q37682448-3928B1ED-52D5-46CA-BB99-CAA3DA7AFB04 Q37698781-4C607F6E-D4A8-4596-9079-2EDE470A9EEB Q37982809-FCA27264-96C2-48C5-9638-006F1766AE33 Q38018539-9CB39322-7D9F-4FD8-AC9D-57FC5E17F292 Q38121575-C4B19577-02A1-45CE-BE0C-475A97955680 Q38366661-0CDDC2B4-C550-439E-B6E5-F47080ACA8BC Q38525797-3680C2A9-8B9C-4D41-BAD6-18A09FEDB429 Q38902371-DB3F8CE2-95A4-4C91-9159-BE08766FD789 Q38974002-C9810F1C-293A-41C5-9352-578E8198658C Q38974051-8CA7F471-07A9-44C4-8173-8CE6533C8AFE Q39392481-33BD605F-6943-4BDD-8150-426EC42EFD22 Q40565101-3C961912-0125-4F6F-8A65-D09D24DC96DD Q40787483-FA5DD6E2-F3FD-4173-8999-624CA4B6131C Q43434311-63422CFD-B77B-4A5D-A73F-9D87B744CBFC Q46059784-021D502E-A4B2-40B5-B7D4-908C48428FA9 Q47980556-FC89EDD4-61A9-49AE-BF41-32815B190515 Q52647780-23CBD082-7759-4BB6-8057-C97D30CD1CE2

P2860

Suppression of innate immunity (natural killer cell/interferon-γ) in the advanced stages of liver fibrosis in mice.

http://www.wikidata.org/entity/Q34816420

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Suppression of innate immunity ...... ges of liver fibrosis in mice.

@ast

Suppression of innate immunity ...... ges of liver fibrosis in mice.

@en

Suppression of innate immunity

@nl

type

label

Suppression of innate immunity ...... ges of liver fibrosis in mice.

@ast

Suppression of innate immunity ...... ges of liver fibrosis in mice.

@en

Suppression of innate immunity

@nl

prefLabel

Suppression of innate immunity ...... ges of liver fibrosis in mice.

@ast

Suppression of innate immunity ...... ges of liver fibrosis in mice.

@en

Suppression of innate immunity

@nl

P1433

Q34816420-798E73BC-C0B3-418A-A4C8-48DB683FD17A

P1476

Q34816420-7E8F52E9-5581-450E-86DD-FA7D5CEC4BFA

P2093

Q34816420-04BBF5C4-69EB-4A14-8865-100F743FF74F

Q34816420-1D5B81B9-4D48-4AAE-9EFB-CEC6C2BA1227

Q34816420-1EDCA3D1-5411-4FC4-B5EB-0E3446EEF9A0

Q34816420-247A578D-F6E5-424E-8FA6-CA2EC02FE2B1

Q34816420-2AA8537A-052E-493C-961B-35E96A54A6DC

Q34816420-332392D6-4C19-4ADF-8053-454AFB0F485C

Q34816420-6218FF29-734D-4CAC-AD16-A69C6C90DCC9

Q34816420-6AAC5BED-2318-4EEA-B01B-7BC499F70B96

Q34816420-865FD698-AAD3-4F7E-BCFB-A219397EEC90

Q34816420-FD0D8BCD-DE00-46D9-BD37-EE5F740A9465

P2860

Q34816420-03C5FAD5-4320-4DCF-B40F-40E7E57D284E

Q34816420-0595C35F-511F-4A43-816E-D03FA0EC5B7E

Q34816420-0D5520C5-4C62-425F-9536-9F531C947E77

Q34816420-2D68B4A8-EC7C-413C-B1B0-8CB32F0EBC79

Q34816420-2FAEE2BC-5952-43A5-994D-6AE9A21500D2

Q34816420-46DEE131-BB5F-48E4-BA16-BFCF24817B5D

Q34816420-47000B1D-A143-4B42-B2CB-830621014DE9

Q34816420-5AE96544-E958-4E20-8D88-0BDFBCF711D4

Q34816420-5F928E6D-A6AD-4B6C-ADCD-48ABB41DD7B0

Q34816420-69E1ABEA-CF03-4B11-9D35-E6496FAEF823

P304

Q34816420-5A058DD8-3BC6-4895-AEBF-522AC6D43522

P31

Q34816420-65B356FD-EDF0-4956-8638-3F083707BC3D

P356

Q34816420-D4062C0E-92E5-4CFA-AFD6-452105CCE2C2

P407

Q34816420-3F9BD5EB-473A-4488-803D-5117474E560A

P433

Q34816420-34A222A5-F174-43EB-B472-CED64EB8E62C

P478

Q34816420-ADD56B49-D085-4E6F-85F8-E64A9D554AC4

P50

Q34816420-C4AD24F2-EA50-487B-A74A-D66207A6B06C

P577

Q34816420-D021BDB0-E9A4-419F-A23A-B2688E5E059F

P5875

Q34816420-4FB9A528-D934-43DC-87DD-E7D2F25165B3

P698

Q34816420-AB1AB623-9649-466F-B6D4-230DEA8957FD

P932

Q34816420-43317728-120B-48BA-87F8-B73FEA69B02F

P356

P1433

P1476

Suppression of innate immunity ...... ges of liver fibrosis in mice.

@en

P2093

Andrew M Miller

http://www.w3.org/2001/XMLSchema#string

Bin Gao

http://www.w3.org/2001/XMLSchema#string

Earl Choi

http://www.w3.org/2001/XMLSchema#string

Hyojin Ko

http://www.w3.org/2001/XMLSchema#string

Ja-Kyung Kim

http://www.w3.org/2001/XMLSchema#string

Jin-Seok Byun

http://www.w3.org/2001/XMLSchema#string

Ogyi Park

http://www.w3.org/2001/XMLSchema#string

So-Young Park

http://www.w3.org/2001/XMLSchema#string

Won-Il Jeong

http://www.w3.org/2001/XMLSchema#string

Yang-Gun Suh

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-inflammatory roles of retinoic acid in rat brain astrocytes: Suppression of interferon-gamma-induced JAK/STAT phosphorylation

Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver

Mechanisms of hepatic fibrogenesis

Interactions of retinoid binding proteins and enzymes in retinoid metabolism.

Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis

Cytosolic retinoid dehydrogenases govern ubiquitous metabolism of retinol to retinaldehyde followed by tissue-specific metabolism to retinoic acid.

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.

SOCS1: a potent and multifaceted regulator of cytokines and cell-mediated inflammation.

Liver: An organ with predominant innate immunity.

NK and NKT cells in liver injury and fibrosis.

P304

1342-1351

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.24190

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51039251

http://www.w3.org/2001/XMLSchema#string

P698

21480338

http://www.w3.org/2001/XMLSchema#string

P932

3079530

http://www.w3.org/2001/XMLSchema#string